Serogroup c
Meningococcal disease serogroup C
15
Kinetics of Antibody Persistence following Administration of a Combination Meningococcal Serogroup C and Haemophilus influenzae Type b Conjugate Vaccine in Healthy Infants in the United Kingdom Primed with a Monovalent Meningococcal Serogroup C Vaccine
6
Multicenter comparison of Neisseria meningitidis serogroup C anti capsular polysaccharide antibody levels measured by a standardized enzyme linked immunosorbent assay
8
Emergence of a new clone of serogroup C Neisseria meningitidis in São Paulo, Brazil
5
Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? experience from the Netherlands
6
Genotyping of outbreak related and sporadic isolates of Clostridium difficile belonging to serogroup C
7
Evidence of a Functional B-Cell Immunodeficiency in Adults Who Experience Serogroup C Meningococcal Disease
7
Relationship between Serum Bactericidal Activity and Serogroup-Specific Immunoglobulin G Concentration for Adults, Toddlers, and Infants Immunized with Neisseria meningitidis Serogroup C Vaccines
5
Combined Administration of Meningococcal Serogroup B Outer Membrane Vesicle Vaccine and Conjugated Serogroup C Vaccine Indicated for Prevention of Meningococcal Disease Is Safe and Immunogenic
7
Seroprevalence of Antibodies against Serogroup C Meningococci in England in the Postvaccination Era
5
Emergence of serogroup C meningococcal disease associated with a high mortality rate in Hefei, China
8
Maintenance of Immune Response throughout Childhood following Serogroup C Meningococcal Conjugate Vaccination in Early Childhood
5
Meningococcal carriage, alcohol consumption, and campus bar patronage in a serogroup C meningococcal disease outbreak
5
Salmonella Serogroup C: Current Status of Vaccines and Why They Are Needed
9
Results from a Randomized Clinical Trial of Coadministration of RotaTeq, a Pentavalent Rotavirus Vaccine, and NeisVac-C, a Meningococcal Serogroup C Conjugate Vaccine
7
Functional T-Cell Deficiency in Adolescents Who Experience Serogroup C Meningococcal Disease despite Receiving the Meningococcal Serogroup C Conjugate Vaccine
7
Serogroup C meningococci in Italy in the era of conjugate menC vaccination
8
Characterization of Neisseria meningitidis serogroup C by multilocus enzyme electrophoresis and ribosomal DNA restriction profiles (ribotyping)
6
Immunologic Hyporesponsiveness to Serogroup C but Not Serogroup A following Repeated Meningococcal A/C Polysaccharide Vaccination in Saudi Arabia
6
Kinetics of Meningococcal Serogroup C-Specific Functional Antibody Levels Up to 15 Years after a Single Immunization with a Meningococcal Serogroup C Conjugate Vaccine during Adolescence
9